MassDevice3d
FDA clears outpatient cardiac telemetry for SmartCardia ECG patch
SmartCardia announced today that it received FDA clearance for mobile outpatient cardiac telemetry (OCT/MCT) for its ECG ...
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
SmartCardia has received FDA clearance for Mobile Outpatient Cardiac Telemetry (OCT/MCT) for its 7-lead live ECG monitoring ...
Benzinga.com25d
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
The Zio AT device is a prescription-only outpatient cardiac telemetry device, commonly called a mobile cardiac telemetry device, used to provide mobile cardiac telemetry (MCT) services.
Medscape1mon
Current and Emerging Indications for Implantable Cardiac Monitors
short-lasting and/or invalidating symptoms; very compliant patients Infrequent, short-lasting and/or invalidating symptoms; noncompliant patients MCOT = mobile cardiac outpatient telemetry.
Yahoo Finance26d
iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT
The Zio AT device is a prescription-only mobile cardiac telemetry (MCT) system for outpatient cardiac monitoring. It includes the Zio AT patch, which records ECG data for up to 14 days ...
Morningstar4d
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
LAUSANNE, Switzerland, Nov. 13, 2024 /PRNewswire/ -- SmartCardia has received FDA clearance for Mobile Outpatient Cardiac Telemetry (OCT/MCT) for its 7-lead live ECG monitoring patch and cloud ...
Mena FN4d
Smartcardia Receives FDA Clearance For Outpatient Cardiac Telemetry For Its 7-Lead ECG Patch And Cloud Platform
SmartCardia's patch and cloud platform is a single solution for complete cardiology practice: the patch can be used in any of the modes from holter to mobile telemetry and can also be remotely ...